Do patients receiving marstacimab need irradiated blood products?

No direct evidence for needing irradiated blood products specifically for patients receiving marstacimab alone was identified. Decisions should be based on individual patient risk factors for TA-GVHD.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-28
DOI
https://doi.org/10.5281/zenodo.23733173
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Do patients receiving marstacimab need irradiated blood products?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Blood transfusion and management
article

Do patients receiving marstacimab need irradiated blood products?

Tripdatabase
article en

Abstract

No direct evidence for needing irradiated blood products specifically for patients receiving marstacimab alone was identified. Decisions should be based on individual patient risk factors for TA-GVHD.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 14%
Blood transfusion and management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Do patients receiving marstacimab need irradiated blood products? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS